Validating whole-airway CFD predictions of DPI aerosol deposition at multiple flow rates

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 29, Issue 6, 2016, Pages 461-481

  Longest, P Worth ^a,b   Tian, Geng ^a   Khajeh Hosseini Dalasm, Navvab ^a   Hindle, Michael ^b  

^a Virginia Commonwealth University   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Computational fluid dynamics (CFD); Pharmaceutical aerosols; Predictions of aerosol deposition; Respiratory drug delivery; Stochastic individual pathway model

Indexed keywords

BUDESONIDE; AEROSOL; BRONCHODILATING AGENT; GLUCOCORTICOID;

ADULT; AEROSOL; ARTICLE; COMPARATIVE STUDY; COMPUTATIONAL FLUID DYNAMICS; CONTROLLED STUDY; DRY POWDER INHALER; FLOW RATE; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; INHALATION; NORMAL HUMAN; PARTICLE SIZE; PREDICTION; SIMULATION; VALIDATION STUDY; WAVEFORM; ANATOMIC MODEL; ANATOMY AND HISTOLOGY; BREATHING; CHEMISTRY; COMPUTER SIMULATION; DRUG FORMULATION; INHALATIONAL DRUG ADMINISTRATION; MARKOV CHAIN; METABOLISM; REPRODUCIBILITY; RESPIRATORY SYSTEM; TISSUE DISTRIBUTION;

ADMINISTRATION, INHALATION; ADULT; AEROSOLS; BRONCHODILATOR AGENTS; BUDESONIDE; COMPUTER SIMULATION; DRUG COMPOUNDING; DRY POWDER INHALERS; GLUCOCORTICOIDS; HUMANS; MODELS, ANATOMIC; PARTICLE SIZE; REPRODUCIBILITY OF RESULTS; RESPIRATION; RESPIRATORY SYSTEM; STOCHASTIC PROCESSES; TISSUE DISTRIBUTION;

EID: 85002876953     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2015.1281     Document Type: Article

References (103)

1. Longest PW, Tian G, Walenga RL, and Hindle M: Comparing MDI and DPI aerosol deposition using in vitro experiments and a new stochastic individual path (SIP) model of the conducting airways. Pharm Res. 2012;29: 1670-1688.
2. Finlay WH, and Martin AR: Recent advances in predictive understanding of respiratory tract deposition. J Aerosol Med Pulm Drug Deliv. 2008;21:189-205.
3. Son Y-J, Longest PW, Tian G, and Hindle M: Evaluation and modification of commercial dry powder inhalers for the aerosolization of submicrometer excipient enhanced growth (EEG) formulation. Eur J Pharm Sci. 2013;49: 390-399.
4. Behara SRB, Longest PW, Farkas DR, and Hindle M: Development and comparison of new high-efficiency dry powder inhalers for carrier-free formulations. J Pharm Sci. 2014;103:465-477.
5. Tian G, Hindle M, and Longest PW: Targeted lung delivery of nasally administered aerosols. Aerosol Sci Technol. 2014;48:434-449.
6. Tian G, Longest PW, Li X, and Hindle M: Targeting aerosol deposition to and within the lung airways using excipient enhanced growth. J Aerosol Med Pulm Drug Deliv. 2013;26:248-265.
7. Lee SL, Adams WP, Li BV, Conner DP, Chowdhury BA, and Yu LX: In vitro considerations to support bioequi-valence of locally acting drugs in dry powder inhalers for lung diseases. AAPS J. 2009;11:414-423.
8. O'Connor D, Adams WP, Chen M-L, Daley-Yates P, Davis J, Derendorf H, Ducharme MP, Fuglsang A, Herrle M, Hochhaus G, Holmes SM, Lee SL, Li BV, Lyapustina S, Newman S, Oliver M, Patterson B, Peart J, Poochikian G, Roy P, Shah T, Singh GJP, and Sharp SS: Role of pharmacokinetics in establishing bioequivalence for orally inhaled drug products: Workshop summary report. J Aerosol Med Pulm Drug Deliv. 2011;24:119-135.
9. Finlay WH, and Martin AR: Modeling of aerosol deposition within interface devices. J Aerosol Med. 2007;20: S19-S26.
10. Martin AR, and Finlay WH: A general, algebraic equation for predicting total respiratory tract deposition of micrometer-sized aerosol particles in humans. J Aerosol Sci. 2007;38:246-253.
11. Byron PR, Hindle M, Lange CF, Longest PW, McRobbie D, Oldham MJ, Olsson B, Thiel CG, Wachtel H, and Finlay WH: In vivo-in vitro correlations: Predicting pulmonary drug deposition from pharmaceutical aerosols. J Aerosol Med Pulm Drug Deliv. 2010;23:S59-S69.
12. Longest PW, and Holbrook LT: In silico models of aerosol delivery to the respiratory tract. Development and applications. Adv Drug Deliv Rev. 2012;64:296-311.
13. Patton JS, Brain JD, Davies LA, Fiegel J, Gumbleton M, Kim KJ, Sakagami M, Vanbever R, and Ehrhardt C: The particle has landed. Characterizing the fate of inhaled pharmaceuticals. J Aerosol Med Pulm Drug Deliv. 2010; 23:S71-S87.
14. Patton JS, and Byron PR: Inhaling medicines: Delivering drugs to the body through the lungs. Nature Rev Drug Discov. 2007;6:67-74.
15. Rygg A, and Longest PW: Absorption and clearance of pharmaceutical aeorsols in the human nose: Development of a CFD model. J Aerosol Med Pulm Drug Deliv. 2016; DOI: 10.1089/jamp.2015.1252. (in press).
16. Tian G, Longest PW, Su G, Walenga RL, and Hindle M: Development of a stochastic individual path (SIP) model for predicting the tracheobronchial deposition of pharmaceutical aerosols: Effects of transient inhalation and sampling the airways. J Aerosol Sci. 2011;42:781-799.
17. Longest PW, Tian G, Delvadia R, and Hindle M: Development of a stochastic individual path (SIP) model for predicting the deposition of pharmaceutical aerosols: Effects of turbulence, polydisperse aerosol size, and evaluation of multiple lung lobes. Aerosol Sci Technol. 2012;46:1271-1285.
18. Tian G, Longest PW, Su G, and Hindle M: Characterization of respiratory drug delivery with enhanced condensational growth (ECG) using an individual path model of the entire tracheobronchial airways. Ann Biomed Engineer. 2011;39:1136-1153.
19. Stahlhofen W, Rudolf G, and James AC: Intercomparison of experimental regional aerosol deposition data. J Aerosol Med. 1989;2:285-308.
20. DeHaan WH, and Finlay WH: Predicting extrathoracic deposition from dry powder inhalers. J Aerosol Sci. 2004; 35:309-331.
21. Choi J, and Kim CS: Mathematical analysis of particle deposition in human lungs: An improved single path transport model. Inhal Toxicol. 2007;19:925-939.
22. Asgharian B, Hofmann W, and Bergmann R: Particle deposition in a multiple-path model of the human lung. Aerosol Sci Technol. 2001;34:332-339.
23. Martonen TB: Analytical model of hygroscopic particle behavior in human airways. Bull Math Biol. 1982;44:425-442.
24. Isaacs KK, Rosati JA, and Martonen TB: Mechanisms of particle deposition. In: Aerosols Handbook, edited by LS Ruzer and NH Harley. CRC Press, New York, pp. 75-99, 2005.
25. Martonen TB: Mathematical model for the selective deposition of inhaled pharmaceuticals. J Pharm Sci. 1993; 82:1191-1199.
26. Koblinger L, and Hofmann W: Monte Carlo modeling of aerosol deposition in human lungs. Part I: Simulation of particle transport in a stochastic lung structure. J Aerosol Sci. 1990;21:661-674.
27. Kim CS: Deposition of aerosol particles in human lungs: In vivo measurement and modeling. Biomarkers. 2009;14: 54-58.
28. ICRP: Human Respiratory Tract Model for Radiological Protection. Elsevier Science Ltd., New York, 1994.
29. Phalen RF, Cuddihy RG, Fisher RG, Moss OR, Schle-singer RB, Swift DL, and Yeh HC: Main features of the proposed NCRP respiratory tract dosimetry model. Rad Protect Dosimetry. 1991;38:179-184.
30. Longest PW, Hindle M, Das Choudhuri S, and Xi J: Comparison of ambient and spray aerosol deposition in a standard induction port and more realistic mouth-throat geometry. J Aerosol Sci. 2008;39:572-591.
31. Katz I, Pichelin M, Caillibotte G, Montesantos S, Majoral C, Martonen T, Fleming J, Bennett M, and Conway J: Controlled, parametric, individualized, 2D, and 3D imaging measurements of aerosol deposition in the respiratory tract of healthy human subjects: Preliminary comparisons with simulations. Aerosol Sci Technol. 2013;47-: 714-723.
32. Conway J, Fleming J, Majoral C, Katz I, Perchet D, Peebles C, Tossici-Bolt L, Collier L, Caillibotte G, Pi-chelin M, Sauret-Jackson V, Martonen T, Apiou-Sbirlea G, Muellinger B, Kroneberg P, Gleske J, Scheuch G, Texereau J, Martin A, Montesantos S, and Bennett M: Controlled, parametric, individualized, 2-D and 3-D imaging measurements of aerosol deposition in the respiratory tract of healthy human subjects for model validation. J Aerosol Sci. 2012;52:1-17.
33. Fleming JS, Epps BP, Conway JH, and Martonen TB: Comparison of SPECT aerosol deposition data with a human respiratory tract model. Deposition clearance and effects in the lung. J Aerosol Med 2006;19:268-278.
34. Delvadia RR, Longest PW, Hindle M, and Byron PR: In vitro tests for aerosol deposition. III: Effect of inhaler insertion angle on aerosol deposition. J Aerosol Med Pulm Drug Deliv. 2013;26:145-156.
35. Ilie M, Matida EA, and Finlay WH: Asymmetrical aerosol deposition in an idealized mouth with a DPI mouthpiece inlet. Aerosol Sci Technol. 2008;42:10-17.
36. Matida EA, DeHaan WH, Finlay WH, and Lange CF: Simulation of particle deposition in an idealized mouth with different small diameter inlets. Aerosol Sci Technol. 2003;37:924-932.
37. Lambert AR, O'Shaughnessy PT, Tawhai MH, Hoffman EA, and Lin C-L: Regional deposition of particles in an image-based airway model: Large-eddy simulation and left-right lung ventilation asymmetry. Aerosol Sci Tech-nol. 2011;45:11-25.
38. Ma B, and Lutchen KR: CFD simulations of aerosol deposition in an anatomically based human large-medium airway model. Ann Biomed Eng. 2009;37:271-285.
39. Xi J, Longest PW, and Martonen TB: Effects of the laryn-geal jet on nano- and microparticle transport and deposition in an approximate model of the upper tracheobronchial airways. J Appl Physiol. 2008;104:1761-1777.
40. Longest PW, Vinchurkar S, and Martonen TB: Transport and deposition of respiratory aerosols in models of childhood asthma. J Aerosol Sci. 2006;37:1234-1257.
41. Lin C-L, Tawhai MH, McLennan G, and Hoffman EA: Multiscale simulation of gas flow in subject-specific models of the human lung. IEEE Eng Med Biol. 2009; 28:25-33.
42. Kleinstreuer C, and Zhang Z: An adjustable triple-bifurcation unit model for air-particle flow simulations in human tracheobronchial airways. J Biomech Eng. 2009;131: 021007.
43. Walters DK, and Luke WH: A method for three-dimensional Navier Stokes simulations of large-scale regions of the human lung airway. J Fluids Eng. 2010;132:051101
44. Walters DK, and Luke WH: Computational fluid dynamics simulations of particle deposition in large-scale multigener-ational lung models. J Biomech Eng. 2011;133:011003.
45. Ferron GA, Oberdorster G, and Hennenberg R: Estimation of the deposition of aerosolised drugs in the human respiratory tract due to hygroscopic growth. J Aerosol Med. 1989;2:271.
46. Hashish AH, Bailey AG, and Williams TJ: Selective deposition of pulsed charged aerosols in the human lung. J Aerosol Med. 1994;7:167-171.
47. Finlay WH: Estimating the type of hygroscopic behavior exhibited by aqueous droplets. J Aerosol Med. 1998;11:221-229.
48. Longest PW, and Hindle M: Evaluation of the Respimat Soft Mist inhaler using a concurrent CFD and in vitro approach. J Aerosol Med Pulm Drug Deliv. 2009;22:99-112.
49. Longest PW, Hindle M, and Das Choudhuri S: Effects of generation time on spray aerosol transport and deposition in models of the mouth-throat geometry. J Aerosol Med Pulmonary Drug Deliv. 2009;22:67-84.
50. Holbrook LT, and Longest PW: Validating CFD predictions of highly localized aerosol deposition in airway models: In vitro data and effects of surface properties. J Aerosol Sci. 2013;59:6-21.
51. Longest PW, and Vinchurkar S: Validating CFD predictions of respiratory aerosol deposition: Effects of upstream transition and turbulence. J Biomech. 2007;40: 305-316.
52. Longest PW, and Oldham MJ: Numerical and experimental deposition of fine respiratory aerosols: Development of a two-phase drift flux model with near-wall velocity corrections. Aerosol Sci. 2008;39:48-70.
53. Khajeh-Hosseini-Dalasm N, and Longest PW: Deposition of particles in the alveolar airways: Inhalation and breath-hold with pharmaceutical aerosols. J Aerosol Sci. 2015; 79:15-30.
54. Kleinstreuer C, Shi H, and Zhang Z: Computational analyses of a pressurized metered dose inhaler and an new drug-aerosol targeting methodology. J Aerosol Med. 2007; 20:294-309.
55. Vinchurkar S, De Backer L, Vos WG, Van Holsbeke C, De Backer J, and De Backer W: A case series on lung deposition analysis of inhaled medication using functional imaging based computational fluid dynamics in asthmatic patients: effect of upper airway morphology and com-parision with in vivo data. Inhal Toxicol. 2012;24:81-88.
56. Oakes JM, Marsden AL, Grandmont C, Shadden SC, Darquenne C, and Vignon-Clementel IE: Airflow and particle deposition simulations in health and emphysema: From in vivo to in silico animal experiments. Ann Biomed Eng. 2014;42:899-914.
57. Oakes JM, Marsden AL, Grandmont C, Darquenne C, and Vignon-Clementel IE: Distribution of aerosolized particles in healthy and emphysematous rat lungs: Comparison between experimental and numerical studies. J Biomech. 2015;48:1147-1157.
58. Delvadia R, Hindle M, Longest PW, and Byron PR: In vitro tests for aerosol deposition II: IVIVCs for different dry powder inhalers in normal adults. J Aerosol Med Pulm Drug Deliv. 2013;26:138-144.
59. Delvadia R, Longest PW, and Byron PR: In vitro tests for aerosol deposition. I. Scaling a physical model of the upper airways to predict drug deposition variation in normal humans. J Aerosol Med. 2012;25:32-40.
60. Zhang Y, Gilbertson K, and Finlay WH: In vivo-in vitro comparison of deposition in three mouth-throat models with Qvar and Turbuhaler inhalers. J Aerosol Med. 2007; 20:227-235.
61. Tian G, Hindle M, Lee S, and Longest PW: Validating CFD predictions of pharmaceutical aerosol deposition with in vivo data. Pharm Res. 2015;32:3170-3187.
62. Newman SP, Pitcairn GR, Hirst PH, Bacon RE, O'Keefe E, Reiners M, and Hermann R: Scintigraphic comparison of budesonide deposition from two dry powder inhalers. Eur Resp J. 2000;16:178-183.
63. Bennett WD, and Smaldone GC: Human variation in the peripheral air-space deposition of inhaled particles. J Appl Physiol. 1987;62:1603-1610.
64. Heyder J, Gebhart J, Rudolf G, Schiller CF, and Stahl-hofen W: Deposition of particles in the human respiratory tract in the size range of 0.005-15 microns. J Aerosol Sci. 1986;17:811-825.
65. Newman SP, Moren F, Trofast E, Talaee N, and Clarke SW: Deposition and clinical efficacy of terbutaline sul-phase from Turbuhaler, a new multi-dose powder inhaler. Eur Respir J. 1989;2:247-252.
66. Newman SP, Pitcairn GR, Hirst RH, and Rankin L: Radionuclide imaging technolgies and their use in evaluating asthma drug deposition in the lungs. Adv Drug Deliv Rev. 2003;55:851-867.
67. Biddiscombe MF, Meah SN, Underwood SR, and Usmani OS: Comparing lung regions of interest in gamma scin-tigraphy for assessing inhaled therapeutic aerosol deposition. J Aerosol Med Pulm Drug Deliv. 2011;24:165-173.
68. Newman S, Bennett WD, Biddiscombe M, Devadason SG, Dolovich MB, Fleming J, Haeussermann S, Kietzig C, Kuehl PJ, Laube BL, Sommerer K, Taylor G, Usmani OS, and Zeman KL: Standardization of techniques for using planar (2D) imaging for aerosol deposition assessment of orally inhaled products. J Aerosol Med Pulm Drug Deliv. 2012;25:S10-S28.
69. Delvadia RR: In vitro methods to predict aerosol drug deposition in normal adults (Unpublished doctoral dissertation). Virginia Commonwealth University, Richmond. 2012.
70. Wong W, Fletcher DF, Traini D, Chan HK, and Young PM: The use of computational approaches in inhaler development. Adv Drug Deliv Rev. 2012;64:312-322.
71. Longest PW, Son Y-J, Holbrook LT, and Hindle M: Aerodynamic factors responsible for the deaggregation of carrier-free drug powders to form micrometer and sub-micrometer aerosols. Pharm Res. 2013;30:1608-1627.
72. De Boer AH, Hagedoorn P, Gjaltema D, Goede J, and Frijlink HW: Air classifier technology (ACT) in dry powder inhalation Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures. Intl J Pharm. 2003;260:187-200.
73. Tarsin WY, Pearson SB, Assi KH, and Chrystyn H: Emitted dose estimates from Seretide (R) Diskus (R) and Symbicort (R) Turbuhaler (R) following inhalation by severe asthmatics. Intl J Pharm. 2006;316:131-137.
74. Below A, Bickmann D, and Breitkreutz J: Assessing the performance of two dry powder inhalers in preschool children using an idealized pediatric upper airway model. Intl J Pharm. 2013;444:169-174.
75. Wachtel H, Bickmann D, Breitkreutz J, and Langguth P: Can pediatric throat models and air flow profiles improve our dose finding strategy. Resp Drug Deliv. 2010;2010: 195-204.
76. Finlay WH, and Gehmlich MG: Inertial sizing of aerosol inhaled from two dry powder inhalers with realistic breath patterns versus constant flow rates. International J Pharm. 2000;210:83-95.
77. Xi J, and Longest PW: Transport and deposition of micro-aerosols in realistic and simplified models of the oral airway. Ann Biomed Eng. 2007;35:560-581.
78. Walenga RL, Tian G, and Longest PW: Development of characteristic upper tracheobronchial airway models for testing pharmaceutical aerosol delivery. ASME J Biomech Eng. 2013;135:091010.
79. Cheng KH, Cheng YS, Yeh HC, and Swift DL: Measurements of airway dimensions and calculation of mass transfer characteristics of the human oral passage. J Bio-mech Eng. 1997;119:476-482.
80. Yeh HC, and Schum GM: Models of human lung airways and their application to inhaled particle deposition. Bull Math Biology. 1980;42:461-480.
81. Vinchurkar S, and Longest PW: Evaluation of hexahedral, prismatic and hybrid mesh styles for simulating respiratory aerosol dynamics. Computers Fluids. 2008;37:317-331.
82. Longest PW, and Vinchurkar S: Effects of mesh style and grid convergence on particle deposition in bifurcating airway models with comparisons to experimental data. Med Eng Physics. 2007;29:350-366.
83. Heistracher T, and Hofmann W: Physiologically realistic models of bronchial airway bifurcations. J Aerosol Sci. 1995;26:497-509.
84. Phalen RF, Yeh HC, Schum GM, and Raabe OG: Application of an idealized model to morphometry of the mammalian tracheobronchial tree. Anat Rec 1978;190: 167-176.
85. Ghalichi F, Deng X, Champlain AD, Douville Y, King M, and Guidoin R: Low Reynolds number turbulence modeling of blood flow in arterial stenoses. Biorheology. 1998;35:281-294.
86. Wilcox DC: Turbulence Modeling for CFD, 2nd Ed. DCW Industries, Inc., California, 1998.
87. Longest PW, and Xi J: Condensational growth may contribute to the enhanced deposition of cigarette smoke particles in the upper respiratory tract. Aerosol Sci Technol. 2008;42:579-602.
88. Longest PW, Kleinstreuer C, and Buchanan JR: Efficient computation of micro-particle dynamics including wall effects. Computers Fluids. 2004;33:577-601.
89. Longest PW, and Xi J: Effectiveness of direct Lagrangian tracking models for simulating nanoparticle deposition in the upper airways. Aerosol Sci Technol. 2007;41:380-397.
90. Gosman AD, and Ioannides E: Aspects of computer simulation of liquid-fueled combustors. J Energy. 1981;7: 482-490.
91. Matida EA, Finlay WH, and Grgic LB: Improved numerical simulation of aerosol deposition in an idealized mouth-throat. J Aerosol Sci. 2004;35:1-19.
92. Wang Y, and James PW: On the effect of anisotropy on the turbulent dispersion and deposition of small particles. Intl J Multiphase Flow. 1999;22:551-558.
93. Horsfield K, Dart G, Olson DE, Filley GF, and Cumming G: Models of the human bronchial tree. J Appl Physiol. 1971;31:207-217.
94. Asgharian B, and Price OT: Airflow distribution in the human lung and its influence on particle deposition. Inhal Toxicol. 2006;18:795-801.
95. Yin Y, Choi J, Hoffman EA, Tawhai MH, and Lin C-L: Simulation of pulmonary air flow with a subject-specific boundary condition. J Biomech. 2010;43:2159-2163.
96. Usmani OS, and Barnes PJ: Assessing and treating small airways disease in asthma and chronic obstructive pulmonary disease. Ann Med. 2012;44:146-156.
97. Longest PW, Hindle M, Das Choudhuri S, and Byron PR: Numerical simulations of capillary aerosol generation: CFD model development and comparisons with experimental data. Aerosol Sci Technol. 2007;41:952-973.
98. Zhang Z, Kleinstreuer C, and Kim CS: Cyclic micron-size particle inhalation and deposition in a triple bifurcation lung airway model. J Aerosol Sci. 2002;33:257-281.
99. Olsson B, Borgstrom L, Lundback H, and Svensson M: Validation of a general in vitro approach for prediction of total lung deposition in healthy adults for pharmaceutical inhalation products. J Aerosol Med Pulm Drug Deliv. 2013;26:355-369.
100. Fleming JS, Sauret V, Conway JH, and Martonen TB: Validation of the conceptual anatomical model of the lung airway. J Aerosol Med-Depos Clearance Effects Lung. 2004;17:260-269.
101. Scheinherr A, Bailly L, Boiron O, Lagier A, Legou T, Pichelin M, Caillibotte G, and Giovanni A: Realistic glottal motion and airflow rate during human breathing. Med Eng Physics. 2015;37:829-839.
102. Wongviriyawong C, Harris RS, Greenblatt E, Winkler T, and Venegas JG: Peripheral resistance: a link between global airflow obstruction and regional ventilation distribution. J Appl Physiol. 2013;114:504-514.
103. Greenblatt EE, Winkler T, Harris RS, Kelly VJ, Kone M, Katz I, Martin AR, Caillibotte G, and Venegas J: What causes uneven aerosol deposition in the bronchocon-stricted lung? A quantitative imaging study. J Aerosol Med Pulm Drug Deliv. 2016;DOI: 10.1089/jamp.2014. 1197.